Results 161 to 170 of about 117,919 (266)

Comparison between liraglutide and dulaglutide on the incidence or progression of eye and kidney complications

Journal of Diabetes Investigation, EarlyView.
We conducted the single‐center, retrospective cohort study to evaluate and compare the risk of diabetic eye and kidney complications between newly initiated once‐daily liraglutide (0.9 mg) and once‐weekly dulaglutide (0.75 mg) in 331 Japanese patients with type 2 diabetes.
Aki Katamine, Junko Oya, Yuichiro Kondo, Yukiko Hasegawa, Tomoko Nakagami   +4 more
wiley   +1 more source

ACTH and renin in 529 healthy youths: associations to sex, puberty and contraceptives. [PDF]

Endocr Connect
Edström PB, Holmboe SA, Vilmann L, Grøndahl VLR, Fritzbøger AFØ, Thomsen CE, Frederiksen H, Schrøder M, Jørgensen NR, Hagen CP, Aksglaede L, Ljubicic ML, Petersen JH, Juul A, Johannsen TH.   +14 more
europepmc   +1 more source

Real‐world risk factors and clinical implications of early estimated glomerular filtration rate decline after sodium‐glucose cotransporter‐2 inhibitor therapy

Journal of Diabetes Investigation, EarlyView.
Older age, atrial fibrillation, loop diuretic use, and higher eGFR variability predicted early eGFR dip. Continued SGLT2 inhibitor therapy preserved long‐term kidney function, although closer monitoring is warranted in patients receiving loop diuretics. ABSTRACT Aim To assess the prevalence, risk factors, estimated glomerular filtration rate trajectory,
Jangwook Lee, Dayoung Kang, Kyoung‐Ah Kim, Han Seok Choi, Soomin Jo, Joeun Kim, Jae Yoon Park, Seung Eun Lee   +7 more
wiley   +1 more source

Precision biomarker discovery in hypertension through explainable AI and proteomics. [PDF]

J Hum Hypertens
Sekaran K, Zayed H.
europepmc   +1 more source

Effects of esaxerenone add‐on therapy versus angiotensin II receptor blocker dose escalation on albuminuria and blood pressure in hypertensive patients with type 2 diabetes: An exploratory randomized study

Journal of Diabetes Investigation, EarlyView.
ABSTRACT Aims Residual albuminuria remains a major clinical challenge in patients with type 2 diabetes mellitus and hypertension despite renin–angiotensin system inhibitor therapy. Esaxerenone, a selective nonsteroidal mineralocorticoid receptor antagonist, reduces albuminuria; however, its effects on oxidative stress remain unclear.
Makoto Ohara, Takemasa Omachi, Nobuaki Takehana, Tomoki Fujikawa, Naoya Osaka, Shunichiro Irie, Michishige Terasaki, Yusaku Mori, Takanori Matsui, Sho‐ichi Yamagishi   +9 more
wiley   +1 more source

The Lingering Battle of Persistent Hypoaldosteronism Following Adrenalectomy for Primary Aldosteronism: A Case Report. [PDF]

J ASEAN Fed Endocr Soc
En Tan J, Merican NSYA, Ismail S, Abdullah NRA.   +3 more
europepmc   +1 more source

Neonatal Acute Kidney Injury—An Australian and New Zealand Perspective

Journal of Paediatrics and Child Health, EarlyView.
ABSTRACT Acute kidney injury (AKI) is increasingly recognized as a critical and underdiagnosed condition among neonates, with significant short and long‐term implications for survival, kidney function, and long‐term cardiovascular health. Neonatal physiology, including ongoing nephrogenesis, immature renal haemodynamics, and limited glomerular ...
Saumil Desai, Thomas Forbes, Simon A. Carter, Alison L. Kent, Chanel Prestidge, David T. Selewski, Eveline Staub, Anke Raaijmakers   +7 more
wiley   +1 more source

Circulating DPP3 limits efficacy of angiotensin II infusion in septic shock. [PDF]

Crit Care
van Lier D, Santos K, Hartmann O, Kox M, Pickkers P.   +4 more
europepmc   +1 more source

Targeting the renin-angiotensin system in sepsis-associated AKI: from pathophysiology to precision medicine. [PDF]

Front Immunol
Dong Y, Xia L, Shou S.
europepmc   +1 more source